# Novel SARS-CoV-2 Point-of-care Testing

> **NCT05034978** · — · TERMINATED · sponsor: **Chinese University of Hong Kong** · enrollment: 150 (actual)

## Conditions studied

- SARS-CoV2 Infection

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT05034978
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-16
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 150 (ACTUAL)
- **Why stopped:** failure in enrolling eligible subjects during COVID-19 outbreaks
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05034978

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05034978, "Novel SARS-CoV-2 Point-of-care Testing". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05034978. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*